期刊文献+

P53、MDM2在基底细胞癌中的表达及意义 被引量:5

The expression and significance of p53 and MDM2 protein in basal cell carcinoma
下载PDF
导出
摘要 目的:研究p53和MDM2蛋白在皮肤基底细胞癌中的表达,探讨基底细胞癌的发生和发展机制。方法:选取50例基底细胞癌标本,30例正常皮肤组织。采用免疫组化S-P法检测p53与MDM2蛋白的表达情况。结果:p53、MDM2蛋白在基底细胞癌组织中的阳性表达率分别为58%(29/50)、46%(23/50),与正常皮肤组织比较,有显著性差异(P<0.05)。基底细胞癌组织中p53蛋白的表达与MDM2蛋白的表达呈正相关(r=0.460)。结论:p53和MDM2蛋白在基底细胞癌中的异常表达,说明在基底细胞癌的发生及发展过程中起重要作用。 Objective To research the expression of p53 and MDM2 protein in cutaneous basal cell carcinoma (BCC), and explore the mechanisms of occurrence and development of the BCC. Methods To detect the expressions of p53 and MDM2 protein in the 50 cases of BCC and 30 cases of normal cutaneous tissues by immunohistochemistry S-P method. Results The positive rate of p53 and MDM2 in the tissues of the 50 cases of BCC were respectively 58% (29/ 50)and 46% (23/50),while in the 30 cases of normal cutaneous tissues neither the expression of p53 nor MDM2 was positive, there were significant difference between them (P〈0.05). Moreover,the expression of p53 was positively correlated with MDM2 protein (r=0.460). Conclusions Abnormal expression of p53 and MDM2 might play important roles in the occurrence and development of BCC.
出处 《中国美容医学》 CAS 2012年第6期939-941,共3页 Chinese Journal of Aesthetic Medicine
关键词 P53 MDM2 基底细胞癌 免疫组织化学 p53 MDM2 basal cell carcinoma immunohistochemistry
  • 相关文献

参考文献8

  • 1Shimizu M,Saitoh Y,Itoh H. Immunohistochemical staining of Ha-rasoncogene product in normal, benign, and malignant human pancreatic tissues[J]. Hum Pathol, 1990,21 (6):607-612.
  • 2Gorji H, Shahbazi N,Habibollahi P,et al.The glutathione-S-transferase P1 polymorphisms correlates with changes in expression of TP53 tumor suppressor in cutaneous basal cell carcinoma [J].J Dermatol Sci,2009,56(3):208-210.
  • 3Adamkov M, Halasova E,Rajcani J, et al. Relation between expression pattern of p53 and survivin in cutaneous basal cell carcinomas [J]. Med Sci Monit,2011,17(3):74-80.
  • 4Ansarin H,Daliri M,Soltani-Arabshahi R. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma[J]. Eur J Dermatol,2006,16(5):543-547.
  • 5Weissman AM.Themes and variations on ubiquitylation [J].Nat RevMol Cell Biol, 2001,2(3): 169-178.
  • 6Momand J,Zambetti GP,Olson DC,et al.The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53 -mediated transactivation[J].Cell, 1992,69(7): 1237-1245.
  • 7Cho HS,Park EJ,Kim CW, et al.Immtmohistochemical Study of p53 and MDM2 Expression on the Epithelial Tumors of the Skin [J]. Korean J Dermatol,2007,45(6):534-540.
  • 8Almquist LM,Karagas MR,Christensen BC,et al.The role of TP53 and MDM2 polymorphisms in TP53 mutagenesis and risk of non-melanoma skin cancer[J].Carcinogelaesis,2011,32(3):327-330.

同被引文献33

  • 1赵松,段惠军,齐凤英,李英敏.bcl-2、p53在皮肤肿瘤中的表达及意义[J].肿瘤研究与临床,2005,17(3):161-163. 被引量:5
  • 2Ceilley Roger I, Del Rosso James Q. Current madalities and new advances in the treatment of basal cell carcinoma [ J ]. Intemational journal of dermatology-, 2006,45 (5) : 489 - 498.
  • 3Telfer N R, Colver G B, Morton C A; British Association of Dermatologists. Guidelines for the management of basal cell carcinoma [ J]. The British j oumal of dermatology, 2008,159 ( 1 ) : 35 - 48 .
  • 4Klara M, Gertruud AM Krekels, Fred HM Nieman , et, al. Surgical excision versus Mohs ' micrographic surgery for primary and recurrent basal - cell carcinoma of the face: a prospective randomised controlled trial with 5 - years ' follow - up[J]. Tile Lancet Oncology, 2008,9 (12):1149- 1156.
  • 5JAMES M. SPENCER. Pilot Study of Imiquimod 5 % Cretan as Adjunctive Therapy to Curettage and Electrodesiccation for Nodular Basal Cell Carcinoma[ J]. Dermatologic surgery,2006,32( 1 ) :63 - 69 .
  • 6Gohara Mona A.Skin cancer in skins of color[J]. Journal of drugs in dermatology: JDD, 2008,7 ( 5 ) : 441 - 445.
  • 7Ting Patricia T, Kasper Richard, Arlette John P. Metastatic basal cell carcinoma: report of two cases and literature review [ J ]. Journal of cutaneous medicine and surgery,2005,9( 1 ) : 10 - 15.
  • 8Samarasinghe Venura, Madan Vishal. Nonmelanoma skin cancer[J]. Journal of cutaneous and aesthetic surgery, 2012,5 (1):3- 10 .
  • 9H Tran, K Chen, S Shumack. Epidemidogy and aetiology of basal cell carcinoma[ J]. The British journal of dermatology, 2003,149 ( S 66) : 50 - 52.
  • 10Ansarin Habib, Daliri Mina, Soltani - Arabshahi Razieh . Expression of p 53 in aggressive and non - aggressive histologic variants of basal cell carcinoma [ J ]. European journal of dermatology: EJD, 2006, 16 (5) :543 - 547.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部